Potential 'significance' of monoclonal gammopathy of 'undetermined significance' during COVID-19 pandemic.
作者信息
Jain Ankur, Ramasamy Karthik
机构信息
Department of Haematology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, United Kingdom of Great Britain and Northern Ireland; NIHR BRC Blood Theme, Oxford, United Kingdom of Great Britain and Northern Ireland; Oxford Myeloma Centre for Translational Research, United Kingdom of Great Britain and Northern Ireland.
出版信息
Blood Cells Mol Dis. 2020 Nov;85:102481. doi: 10.1016/j.bcmd.2020.102481. Epub 2020 Jul 24.
Abstract
摘要
相似文献
1
Potential 'significance' of monoclonal gammopathy of 'undetermined significance' during COVID-19 pandemic.新型冠状病毒肺炎大流行期间意义未明的单克隆丙种球蛋白病的潜在“意义”
Blood Cells Mol Dis. 2020 Nov;85:102481. doi: 10.1016/j.bcmd.2020.102481. Epub 2020 Jul 24.
2
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19.意义未明的单克隆丙种球蛋白病与新型冠状病毒肺炎的病例系列
Br J Haematol. 2020 Aug;190(3):e130-e133. doi: 10.1111/bjh.16906. Epub 2020 Jun 24.
3
Cell-Free Therapies: Novel Approaches for COVID-19.无细胞疗法：治疗新冠肺炎的新方法。
Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.
4
Immune status could be associated with severity in COVID-19 patients.免疫状态可能与新冠肺炎患者的病情严重程度相关。
Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):13-16. doi: 10.1590/1806-9282.66.S2.13. eCollection 2020.
5
COVID-19-a very visible pandemic.新冠疫情——一场极具影响力的大流行病。
Lancet. 2020 Aug 8;396(10248):e17. doi: 10.1016/S0140-6736(20)31675-5.
6
A Call for a Three-Tiered Pandemic Public Health Strategy in Context of SARS-CoV-2.呼吁在新冠病毒背景下制定三级大流行公共卫生战略。
Rejuvenation Res. 2020 Aug;23(4):281-283. doi: 10.1089/rej.2020.2363. Epub 2020 Jun 24.
7
The COVID-19 pandemic and the use of MS disease-modifying therapies.新冠疫情与多发性硬化症疾病修正疗法的使用
Mult Scler Relat Disord. 2020 Apr;39:102073. doi: 10.1016/j.msard.2020.102073. Epub 2020 Mar 27.
8
The immunological case for staying active during the COVID-19 pandemic.新冠疫情期间保持活跃的免疫学依据。
Brain Behav Immun. 2020 Jul;87:6-7. doi: 10.1016/j.bbi.2020.04.041. Epub 2020 Apr 18.
9
New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes".关于新冠肺炎老年患者的新观点：对《老年人中的SARS-CoV-2和新冠肺炎：关于发病机制、免疫反应及预后我们可能了解到的情况》的评论
Geroscience. 2020 Oct;42(5):1225-1227. doi: 10.1007/s11357-020-00232-x. Epub 2020 Jul 24.
10
Good news or bad news? The coronavirus pandemic has sickened and killed only a relatively few people but has affected us all.好消息还是坏消息？新冠疫情仅导致相对较少的人患病和死亡，但却影响了我们所有人。
Croat Med J. 2020 Jul 5;61(3):296-299. doi: 10.3325/cmj.2020.61.296.
引用本文的文献
1
COVID-19-Associated Cold Agglutinin Syndrome and Hemophagocytosis in a Patient with Monoclonal Gammopathy of Undetermined Significance.意义未明单克隆丙种球蛋白病患者的新冠病毒感染相关冷凝集素综合征和噬血细胞作用
Mediterr J Hematol Infect Dis. 2025 Mar 1;17(1):e2025024. doi: 10.4084/MJHID.2025.024. eCollection 2025.
2
Risk and Severity of COVID-19 Infection in Monoclonal Gammopathy of Undetermined Significance: A 3-Year Propensity Matched Cohort Study.意义未明单克隆丙种球蛋白血症患者感染 COVID-19 的风险和严重程度：一项为期 3 年的倾向评分匹配队列研究。
Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):626-632. doi: 10.1016/j.clml.2023.04.010. Epub 2023 Apr 28.
3
Comments on COVID-19 and AL Amyloidosis, the Missing Links.关于新型冠状病毒肺炎与轻链型淀粉样变性：缺失的环节之评论
Am J Med. 2022 Jun;135(6):e137-e138. doi: 10.1016/j.amjmed.2022.02.011.
4
Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study.非重症监护环境中低丙种球蛋白血症对 COVID-19 病程的影响：一项单中心回顾性队列研究。
Front Immunol. 2022 Mar 10;13:842643. doi: 10.3389/fimmu.2022.842643. eCollection 2022.
5
Severe Anemia Due to Cold Agglutinin Syndrome in a COVID-19 Patient with IgM Monoclonal Gammopathy of Undetermined Significance Successfully Treated with Corticosteroids.COVID-19 患者伴意义未明的单克隆免疫球蛋白血症 IgM 型冷自身免疫性溶血性贫血，经皮质类固醇治疗后成功缓解。
Intern Med. 2022 Jun 1;61(11):1789-1793. doi: 10.2169/internalmedicine.8647-21. Epub 2022 Mar 26.
6
Pattern of serum protein capillary electrophoretogram in SARS- CoV-2 infection.新型冠状病毒感染患者血清蛋白毛细管电泳图谱。
Clin Chim Acta. 2022 Feb 15;527:11-16. doi: 10.1016/j.cca.2022.01.003. Epub 2022 Jan 7.
7
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.意义未明的单克隆丙种球蛋白血症与 COVID-19：基于人群的队列研究。
Blood Cancer J. 2021 Dec 1;11(12):191. doi: 10.1038/s41408-021-00580-7.
8
Impact of serological and PCR testing requirements on the selection of COVID-19 convalescent plasma donors.血清学和 PCR 检测要求对 COVID-19 恢复期血浆捐献者选择的影响。
Transfusion. 2021 May;61(5):1461-1470. doi: 10.1111/trf.16293. Epub 2021 Feb 8.
本文引用的文献
1
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers.更正：纽约市多发性骨髓瘤患者的新冠病毒感染及转归：一项来自五个学术中心的队列研究。
Blood Cancer Discov. 2020 Nov 4;1(3):290. doi: 10.1158/2643-3230.BCD-20-0160. eCollection 2020 Nov.
2
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.三等级中心治疗 COVID-19 合并多发性骨髓瘤患者的经验：教训与未来方向。
J Hematol Oncol. 2020 Jul 14;13(1):94. doi: 10.1186/s13045-020-00934-x.
3
Time to Redefine Risk-Stratification and Response Criteria in Immunoglobulin Light Chain Amyloidosis?是否需要重新定义免疫球蛋白轻链淀粉样变性的风险分层和反应标准？
Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e769-e776. doi: 10.1016/j.clml.2020.05.025. Epub 2020 Jun 7.
4
Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID-19.在重症新型冠状病毒肺炎急性抗凝血酶缺乏患者中使用阿加曲班进行抗凝治疗。
Br J Haematol. 2020 Sep;190(5):e286-e288. doi: 10.1111/bjh.16927. Epub 2020 Jun 30.
5
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.COVID-19 大流行期间系统性轻链（AL）淀粉样变性患者管理面临的挑战。
Br J Haematol. 2020 Aug;190(3):346-357. doi: 10.1111/bjh.16898. Epub 2020 Jul 4.
6
A case series of Monoclonal Gammopathy of Undetermined Significance and COVID-19.意义未明的单克隆丙种球蛋白病与新型冠状病毒肺炎的病例系列
Br J Haematol. 2020 Aug;190(3):e130-e133. doi: 10.1111/bjh.16906. Epub 2020 Jun 24.
7
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.羟氯喹或氯喹治疗或预防 COVID-19：一项实时系统评价。
Ann Intern Med. 2020 Aug 18;173(4):287-296. doi: 10.7326/M20-2496. Epub 2020 May 27.
8
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征：前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
9
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.接受全身抗癌治疗的多发性骨髓瘤患者感染严重急性呼吸综合征冠状病毒（COVID-19疾病）出现症状后的临床影响的真实世界评估。
Br J Haematol. 2020 Jul;190(2):e83-e86. doi: 10.1111/bjh.16874. Epub 2020 Jun 10.
10
COVID-19 and myeloma: what are the implications for now and in the future?COVID-19 与骨髓瘤：当下及未来的影响？
Br J Haematol. 2020 Jul;190(2):173-178. doi: 10.1111/bjh.16815. Epub 2020 Jun 25.
Zotero 插件